Healthcare -
Biotechnology - NASDAQ - US
$ 4.12
-1.9 %
$ 230 M
Market Cap
-3.19
P/E
FHTX - REVENUE
Revenue FHTX - Foghorn Therapeutics Inc.
22.6 M
LAST VALUE
8.42%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR